Biomanufacturing Fund - open for applications
Biomanufacturing Fund - open for applications
The Biomanufacturing Fund (BMF) will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of Friday 30 June and Monday 31 July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk.
You can find out more details about the fund here